Archive for December, 2020

BridgeBio Pharma and Maze Therapeutics Establish Joint Venture to Advance Precision Medicine to Treat Cardiovascular Disease

Posted by amanda punzalan under Press (No Respond)

PALO ALTO and SOUTH SAN FRANCISCO, Dec. 7, 2020 – BridgeBio Pharma, Inc. (Nasdaq: BBIO) and Maze Therapeutics today announced the establishment of a joint venture, Contour Therapeutics, focused on transforming and advancing breakthrough precision medicine approaches designed to treat…

Maze Therapeutics and Alloy Therapeutics Form Broadwing Bio to Develop Antibody Therapies for Genetically Validated Targets in Ophthalmic Diseases

Posted by amanda punzalan under Press (No Respond)

SOUTH SAN FRANCISCO, CALIF., and LEXINGTON, MASS., Dec. 7, 2020 – Maze Therapeutics, a company focused on translating genetic insights into new medicines, and Alloy Therapeutics, a company developing platforms and services to enable drug discovery, today announced the formation…